Charles A. Reinhart, III

2018

In 2018, Charles A. Reinhart, III earned a total compensation of $1.4M as Chief Financial Officer at Pacira Pharmaceuticals, a 7% increase compared to previous year.

Compensation breakdown

Bonus$220,000
Option Awards$571,706
Salary$420,827
Stock Awards$191,750
Other$3,390
Total$1,407,673

Reinhart received $571.7K in option awards, accounting for 41% of the total pay in 2018.

Reinhart also received $220K in bonus, $420.8K in salary, $191.8K in stock awards and $3.4K in other compensation.

Rankings

In 2018, Charles A. Reinhart, III's compensation ranked 7,473rd out of 14,244 executives tracked by ExecPay. In other words, Reinhart earned more than 47.5% of executives.

ClassificationRankingPercentile
All
7,473
out of 14,244
48th
Division
Manufacturing
2,899
out of 5,759
50th
Major group
Chemicals And Allied Products
1,089
out of 2,122
49th
Industry group
Drugs
920
out of 1,811
49th
Industry
Pharmaceutical Preparations
722
out of 1,385
48th

Pay ratio

Charles A. Reinhart, III's Pay$1,407,673
Median Employee's Pay$177,153
Pay Ratio

8

to 1

In 2018, the annual total compensation of Charles A. Reinhart, III was $1,407,673.

The annual total compensation of the median employee at Pacira Pharmaceuticals was $177,153.

The ratio of Charles A. Reinhart, III's pay to the pay of median employee was therefore 8 to one.

Source: SEC filing on April 22, 2019.

Reinhart's colleagues

We found four more compensation records of executives who worked with Charles A. Reinhart, III at Pacira Pharmaceuticals in 2018.

2018

David Stack

Pacira Pharmaceuticals

Chief Executive Officer

2018

Dennis McLoughlin

Pacira Pharmaceuticals

Chief Commercial Officer

2018

Richard Scranton

Pacira Pharmaceuticals

Chief Medical Officer

2018

Kristen Williams

Pacira Pharmaceuticals

Chief Administrative Officer

News

You may also like